Gonadotropin release inhibitor

Gonadotropin-releasing hormone inhibitor (GnRH inhibitor), also known as gonadotropin-release inhibitor, is a type of medication used in the management of conditions that are influenced by the pituitary gland's release of gonadotropins LH (luteinizing hormone) and FSH (follicle-stimulating hormone). These conditions include certain types of cancers such as prostate cancer, breast cancer, and medical conditions like endometriosis, uterine fibroids, and precocious puberty. GnRH inhibitors work by decreasing the production of sex hormones (estrogen and testosterone) which are involved in the growth and development of such diseases.

Mechanism of Action

GnRH inhibitors act on the pituitary gland to directly inhibit the secretion of gonadotropins, LH, and FSH. By doing so, they reduce the levels of testosterone and estrogen in the body. This is achieved through a mechanism known as "downregulation." Initially, GnRH inhibitors may cause a temporary surge in gonadotropin levels, leading to a transient increase in sex hormone levels (flare-up effect). However, continuous administration leads to the desensitization of the GnRH receptors in the pituitary gland, resulting in decreased production of LH and FSH, and consequently, a reduction in sex hormone levels.

Clinical Uses

GnRH inhibitors are used in the treatment of hormone-sensitive conditions such as:

• Prostate cancer - where they reduce the levels of testosterone, a hormone that can promote the growth of cancer cells.
• Breast cancer - in premenopausal women, by lowering estrogen levels.
• Endometriosis - by reducing estrogen levels, which can help relieve pain and reduce the size of endometriosis lesions.
• Uterine fibroids - also through the reduction of estrogen levels, which can help shrink fibroids and reduce symptoms.
• Precocious puberty - by suppressing the premature secretion of sex hormones that can cause early puberty.

Side Effects

The use of GnRH inhibitors can lead to several side effects due to the lowered levels of sex hormones. These may include:

• Hot flashes
• Decreased libido
• Vaginal dryness in women
• Erectile dysfunction in men
• Osteoporosis or bone density loss
• Mood changes

Patients undergoing treatment with GnRH inhibitors are often monitored for these side effects, and adjunct therapies may be prescribed to manage them.

Types of GnRH Inhibitors

There are several types of GnRH inhibitors, including:

• Goserelin
• Leuprorelin
• Triptorelin

Each of these medications may be administered via injections or implants, depending on the specific drug and the condition being treated.

Conclusion

GnRH inhibitors play a crucial role in the management of various hormone-sensitive conditions. By inhibiting the production of gonadotropins, these medications effectively reduce the levels of sex hormones in the body, which can help control the progression of diseases such as cancer, endometriosis, and precocious puberty. However, the use of GnRH inhibitors is not without side effects, and careful management and monitoring are required to optimize treatment outcomes.

Resources

Latest articles - Gonadotropin release inhibitor

• Most recent articles
• Ongoing trials

Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Gonadotropin release inhibitor for any updates.

‎